EUVIMEDEUVIMED entdecken
Crossref

CircUGGT2 facilitates progression and cisplatin resistance of bladder cancer through nonhomologous end-joining pathway

Fang Lyu, Sihuai Huang, Zhecheng Yan, Qingliu He, Chunyu Liu, Lulin Cheng, Yukun Cong, Kang Chen, Yarong Song, Yifei Xing

Cellular Signalling · 2024

DOI: 10.1016/j.cellsig.2024.111164 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Signalling, 2024. Verfasst von Fang Lyu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, NO.1277 Jiefang Avenue, Wuhan 430022, C…. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Cisplatin, DNA End-Joining Repair, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Quanzhou City Science and Technology Program, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of resistance to cisplatin (CDDP) in bladder cancer presents a notable obstacle, with indications pointing to the substantial role of circular RNAs (circRNAs) in this resistance. Nevertheless, the precise mechanisms through which circRNAs govern resistance are not yet fully understood. Our findings demonstrate that circUGGT2 is significantly upregulated in bladder cancer, facilitating cancer cell migration and invasion. Additionally, our analysis of eighty patient outcomes revealed a negative correlation between circUGGT2 expression levels and prognosis. Using circRNA pull-down assays, mass spectrometry analyses, and RNA Immunoprecipitation (RIP), it was shown that circUGGT2 interacts with the KU heterodimer, consisting of KU70 and KU80. Both KU70 and KU80 are critical components of the non-homologous end joining (NHEJ) pathway, which plays a role in CDDP resistance. Flow cytometry was utilized in this study to illustrate the impact of circUGGT2 on the sensitivity of bladder cancer cell lines to CDDP through its interaction with KU70 and KU80. Additionally, a reduction in the levels of DNA repair factors associated with the NHEJ pathway, such as KU70, KU80, DNA-PKcs, and XRCC4, was observed in chromatin of bladder cancer cells following circUGGT2 knockdown post-CDDP treatment, while the levels of DNA repair factors in total cellular proteins remained constant. Thus, the promotion of CDDP resistance by circUGGT2 is attributed to its facilitation of repair factor recruitment to DNA breaks via interaction with the KU heterodimer. Furthermore, our study demonstrated that knockdown of circUGGT2 resulted in reduced levels of γH2AX, a marker of DNA damage response, in CDDP-treated bladder cancer cells, implicating circUGGT2 in the NHEJ pathway for DNA repair.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsCisplatinDNA End-Joining RepairDrug Resistance, NeoplasmRNA, CircularKu AutoantigenHumansCell Line, TumorGene Expression Regulation, NeoplasticCell MovementDNA-Binding ProteinsDisease Progression

Stichwörter der Autor:innen

Bladder cancerCircular RNACisplatin resistanceNonhomologous end-joining

Substanzen

CisplatinRNA, CircularKu AutoantigenXrcc6 protein, humanDNA-Binding Proteins

Autor:innen und Institutionen

  • Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, NO.1277 Jiefang Avenue, Wuhan 430022, China.
  • Department of Urology, The Second Affiliated Hospital of Fujian Medical University, NO.34 North Zhongshan Road, Quanzhou 362000, China.
  • Department of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, NO.1277 Jiefang Avenue, Wuhan 430022, China.
  • Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, NO.1277 Jiefang Avenue, Wuhan 430022, China.. Electronic address: tjmusong@126.com.
  • Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, NO.1277 Jiefang Avenue, Wuhan 430022, China.. Electronic address: yfxing@hust.edu.cn.

Förderung

  • Quanzhou City Science and Technology Program
  • National Natural Science Foundation of China

Zitieren

APA

Lyu, F., Huang, S., Yan, Z., He, Q., Liu, C., Cheng, L., Cong, Y., Chen, K., Song, Y., & Xing, Y. (2024). CircUGGT2 facilitates progression and cisplatin resistance of bladder cancer through nonhomologous end-joining pathway. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2024.111164

Vancouver

Lyu F, Huang S, Yan Z, He Q, Liu C, Cheng L, et al. CircUGGT2 facilitates progression and cisplatin resistance of bladder cancer through nonhomologous end-joining pathway. Cellular Signalling. 2024. doi:10.1016/j.cellsig.2024.111164

BibTeX
@article{Lyu2024,
  author = {Lyu, Fang and Huang, Sihuai and Yan, Zhecheng and He, Qingliu and Liu, Chunyu and Cheng, Lulin and Cong, Yukun and Chen, Kang and Song, Yarong and Xing, Yifei},
  title = {CircUGGT2 facilitates progression and cisplatin resistance of bladder cancer through nonhomologous end-joining pathway},
  journal = {Cellular Signalling},
  year = {2024},
  doi = {10.1016/j.cellsig.2024.111164}
}
Kostenlos starten →